Advertisement
UK markets close in 6 hours 27 minutes
  • FTSE 100

    8,095.63
    +55.25 (+0.69%)
     
  • FTSE 250

    19,717.40
    -1.97 (-0.01%)
     
  • AIM

    755.06
    +0.37 (+0.05%)
     
  • GBP/EUR

    1.1673
    +0.0028 (+0.24%)
     
  • GBP/USD

    1.2521
    +0.0058 (+0.47%)
     
  • Bitcoin GBP

    51,037.68
    -2,096.74 (-3.95%)
     
  • CMC Crypto 200

    1,359.43
    -23.14 (-1.67%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CRUDE OIL

    83.01
    +0.20 (+0.24%)
     
  • GOLD FUTURES

    2,337.80
    -0.60 (-0.03%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    18,001.88
    -86.82 (-0.48%)
     
  • CAC 40

    8,061.36
    -30.50 (-0.38%)
     

BUZZ-Synergy Health: worst day in 6.5 yrs on Steris deal fears

** Health outsourcer Synergy Health (LSE: SYR.L - news) dives c.18 pct, its biggest one-day drop since Oct (HKSE: 3366.HK - news) 2008 in heavy volume amid jitters over Steris Corp (NYSE: STE - news) 's proposed takeover of co

** Steris, based near Cleveland, buying out UK's Synergy Health, with combined co to be managed from Ohio - among latest attempts at inversion-type deal, despite Treasury Dept crackdown in Sept slowing inversion deal-making

** These deals typically involve a US co buying a smaller foreign rival, then taking on its nationality for tax purposes, while many core operations remain in US

** US group AbbVie (Xetra: 4AB.DE - news) pulled plug on deal to buy UK's Shire (Xetra: S7E.DE - news) after the changes to the US tax rules

ADVERTISEMENT

** Olivetree flags Synergy/Steris deal into in-depth review territory with US anti-trust regulators & judgement expected soon

** Olivetree highlights FTC hearing scheduled today & although non-public & impossible to confirm topic, market believes this is to review rule on Synergy transaction

Link: http://1.usa.gov/1JVe2KM

** "The rumour is that the FTC is preparing to sue-to-block the transaction, which is the mechanism US regulators use to stop M&A transactions," Olivetree says

** One market maker points to Olivetree note as catalyst for share-price drop

** Stock easily top faller on FTSE 250 index in trading volume at c.3.5x its 90-day daily avg in c.2 hours (RM (LSE: RM.L - news) : tricia.wright1.thomsonreuters.com@reuters.net)